Trump votes early in Florida as Biden warns of COVID-19 'dark winter'    Iran's leader urges penalties for COVID offenders    Real Madrid sink Barcelona in 'Clasico' with help of Ramos penalty    Unstoppable Lewandowski scores hat-trick as Bayern demolish Frankfurt    Ethiopia summons US ambassador over Trump comments in dam dispute    At least 13 killed in suicide bombing at Kabul education centre, Afghan officials    UAE merges insurance authority with central bank: Dubai ruler tweet    BREAKING: EU calls for resumption of Ethiopia dam talks    US sets coronavirus infection record; deaths near 224,000    Asia becomes second region to exceed 10 million coronavirus cases    US removal of Sudan from 'sponsors of terrorism' list is step toward debt relief: IMF    In photos: Egyptian celebrities attend opening of El-Gouna Film Festival's 4th edition    4th El-Gouna Film Festival kicks off despite 'hardships of the cinema industry this year'    Ahly 'still have a lot of work to do before Champions League final': Mosimane    US, Sudan call for amicable solution over Ethiopia dam dispute    Egyptian artefacts among items sprayed with olive oil in several Berlin museums    EgyptAir, Ghana sign MoU to establish national Ghanaian airline    BREAKING: Egypt's central bank dismisses CIB head Hisham Ezz El-Arab over 'serious violations'    Egyptian insurance companies' premiums 9.6% up in five months    Egypt's President Sisi names new head of anti-corruption watchdog    Egypt's offers 18 bln pounds T-bills on Sunday    EgyptAir offering discounts for some international flights    Egypt records 212 new coronavirus cases, 14 deaths on Saturday    Egypt to require PCR coronavirus tests for airport travelers    Egypt sends 125 tonnes of glass by sea to Beirut    Legend Messi officially wants to leave Barcelona, hands transfer request    Global smartphone sales drop 20% in Q2, yet Apple's iPhone sales steady    Sisi: Egypt keen on establishing development projects with Iraq, Jordan    Egyptian megastar Amr Diab releases new hit music video    Making of Harry Potter will be available for fans at new park in Tokyo    Egypt's Senate elections official results to be announced Wednesday    Netflix Egypt is bringing megastar Amr Diab back with a new original    Egypt reopens Rafah border crossing for first time since April    Egypt's senate elections 2020 trending on social media in few days    African Champions League final will be played on Oct. 16-17, CAF says    No room to delay Egyptian Premier League games – EFA's board member    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

Neanderthal genes linked to severe COVID-19; Mosquitoes cannot transmit the coronavirus
Published in Ahram Online on 01 - 10 - 2020

Neanderthal genes linked with severe COVID-19
A group of genes passed down from extinct human cousins is linked with a higher risk for severe COVID-19, researchers say. When they compared the genetic profiles of about 3,200 hospitalized COVID-19 patients and nearly 900,000 people from the general population, they found that a cluster of genes on chromosome 3 inherited from Neanderthals who lived more than 50,000 years ago is linked with 60% higher odds of needing hospitalization. People with COVID-19 who inherited this gene cluster are also more likely to need artificial breathing assistance, coauthor Hugo Zeberg of the Max Planck Institute for Evolutionary Anthropology said in a news release. The prevalence of these genes varies widely, according to a report published on Wednesday in Nature. In South Asia, roughly 30% of people have them, compared to roughly one in six Europeans. They are almost non-existent in Africa and East Asia. While the study cannot explain why these particular genes confer a higher risk, the authors conclude, "with respect to the current pandemic, it is clear that gene flow from Neanderthals has tragic consequences."
Mosquitoes cannot transmit COVID-19
A mosquito that bites a person with COVID-19 cannot pass the coronavirus infection to its next victim, according to a study by researchers from U.S. Department of Agriculture and Kansas State University. Mosquitoes are notorious disease carriers, transmitting West Nile virus, Zika, and many other viruses from person to person and among animals. In laboratory experiments, researchers allowed several species of disease-carrying mosquitoes, plus some other biting insects, to feed on blood spiked with the novel coronavirus, SARS-CoV-2. The virus was unable to survive and replicate itself in any of the insects, they reported in a paper posted on Wednesday on bioRxiv ahead of peer review. "Biting insects do not pose a risk for transmission of SARS-CoV-2 to humans or animals," the researchers said.
Moderna vaccine passes safety test in older patients
Results from an early safety study of Moderna Inc's coronavirus vaccine candidate in older adults showed that it produced immune responses at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots, researchers reported on Tuesday in The New England Journal of Medicine. The findings are reassuring because immunity tends to weaken with age, coauthor Dr. Evan Anderson of Emory University in Atlanta told Reuters. The trial involved 20 adults aged 56 to 70 and another 20 aged 71 and older. Side effects included headache, fatigue, body aches, chills and injection site pain. In most cases, these were mild to moderate. "This is similar to what a lot of older adults are going to experience with the high dose influenza vaccine," Anderson said. Moderna is already testing the vaccine in a large Phase III trial, the final stage before seeking emergency authorization or approval.
Hydroxychloroquine fails to prevent COVID-19
A malaria drug taken by U.S. President Donald Trump to prevent COVID-19 did not help prevent coronavirus infections in healthcare workers in a gold-standard randomized controlled trial conducted at the University of Pennsylvania. The new research, published on Wednesday in JAMA Internal Medicine, shows that routine use of the drug, hydroxychloroquine, cannot be recommended to healthcare workers for prevention of COVID-19, researchers said. The study largely confirms results from a similar trial conducted at the University of Minnesota in which hydroxychloroquine failed to prevent infection among people exposed to the new coronavirus.
Immune differences seen in children with inflammatory syndrome after COVID-19
A new study may shed light on why some youngsters develop the rare and dangerous multisystem inflammatory syndrome in children (MIS-C) after recovering from COVID-19 while most do not. The syndrome can cause severe inflammation of blood vessels, the heart, lungs, kidneys, and other organs. The immune system is more highly activated in children with MIS-C than in those with COVID-19, study co-author Dr. John Wherry of University of Pennsylvania Perelman School of Medicine told Reuters. However, in MIS-C patients, the activated immune system quickly settles down, and symptoms improve, often faster than during a bout with COVID-19. Wherry noted a possible connection between a specific type of activated immune cell in children with MIS-C and some of the vascular complications seen in that condition as well as in COVID-19. "The identification of an immune cell type connected to vascular symptoms may identify a new (treatment) target if approaches can be developed to target such cells," he said. The study was published on Sunday on medRxiv ahead of peer review.

Clic here to read the story from its source.